FABP5 and liver cancer: In esophageal cancer [13, 14], gastric cancer [15, 16], liver cancer [17, 18, 19, 20, 21, 22], and colorectal cancer [23], studies have observed FABP5 overexpression, which correlates with tumor proliferation, invasiveness, and poor patient prognosis.